CARAVITA, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.123
NA - Nord America 2.895
AS - Asia 2.861
SA - Sud America 636
AF - Africa 160
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 13.684
Salva come PNG Salva come JPEG
Nazione #
IE - Irlanda 2.895
US - Stati Uniti d'America 2.750
SG - Singapore 1.398
RU - Federazione Russa 1.297
GB - Regno Unito 989
NL - Olanda 638
CN - Cina 600
BR - Brasile 495
IT - Italia 480
FR - Francia 407
VN - Vietnam 376
DE - Germania 115
ZA - Sudafrica 112
FI - Finlandia 100
CA - Canada 96
HK - Hong Kong 90
SE - Svezia 81
ID - Indonesia 70
IN - India 65
AR - Argentina 56
KR - Corea 41
BD - Bangladesh 40
PL - Polonia 34
MX - Messico 33
TR - Turchia 26
EC - Ecuador 25
IQ - Iraq 25
AT - Austria 21
JP - Giappone 20
PK - Pakistan 17
CO - Colombia 15
ES - Italia 14
MY - Malesia 12
UA - Ucraina 12
PY - Paraguay 11
SA - Arabia Saudita 11
EG - Egitto 10
PE - Perù 10
UZ - Uzbekistan 10
VE - Venezuela 10
ET - Etiopia 9
MA - Marocco 8
NP - Nepal 8
PH - Filippine 8
CL - Cile 7
JM - Giamaica 7
BE - Belgio 6
BG - Bulgaria 6
KE - Kenya 6
LT - Lituania 6
TN - Tunisia 6
EU - Europa 5
IR - Iran 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
KG - Kirghizistan 4
LB - Libano 4
MD - Moldavia 4
UY - Uruguay 4
AZ - Azerbaigian 3
BO - Bolivia 3
CR - Costa Rica 3
JO - Giordania 3
KZ - Kazakistan 3
MN - Mongolia 3
PA - Panama 3
RO - Romania 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
IL - Israele 2
KW - Kuwait 2
NO - Norvegia 2
OM - Oman 2
SN - Senegal 2
TW - Taiwan 2
AM - Armenia 1
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
CV - Capo Verde 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RE - Reunion 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 13.683
Salva come PNG Salva come JPEG
Città #
Dublin 2.865
Southend 840
Singapore 614
San Jose 544
Ashburn 498
Moscow 453
Hefei 208
Princeton 171
Ho Chi Minh City 132
Lauterbourg 108
Johannesburg 101
Council Bluffs 100
New York 100
Boardman 99
Los Angeles 94
Chandler 90
Hanoi 90
The Dalles 86
Hong Kong 81
Beijing 75
Milan 72
Altamura 70
Helsinki 68
Toronto 59
Washington 49
Buffalo 46
São Paulo 46
Wilmington 46
Fairfield 45
Jakarta 45
Frankfurt am Main 41
Redondo Beach 41
Santa Clara 40
Dalmine 35
London 32
Seoul 31
Guangzhou 29
Chicago 28
Ogden 27
Da Nang 25
Lappeenranta 25
Shanghai 23
Munich 22
Amsterdam 19
Bergamo 19
Montreal 19
Rio de Janeiro 19
Shenzhen 19
Nuremberg 18
Reggio Calabria 18
Rome 17
Tokyo 17
Dallas 16
Orem 15
Mexico City 14
Pune 14
San Diego 14
Baghdad 13
Denver 13
Norwalk 13
Eygelshoven 12
Warsaw 12
Ankara 11
Brooklyn 11
Curitiba 11
Tianjin 11
Woodbridge 11
Andover 10
Biên Hòa 10
Chennai 10
Dhaka 10
Haiphong 10
Hangzhou 10
Poplar 10
Ribeirão Preto 10
Addis Ababa 9
Atlanta 9
Boston 9
Brasília 9
Cambridge 9
Guayaquil 9
Lima 9
Manchester 9
Stockholm 9
Tashkent 9
Vienna 9
Assago 8
Bologna 8
Erbil 8
Hounslow 8
Houston 8
Naples 8
Portsmouth 8
Quito 8
San Francisco 8
Seattle 8
Belo Horizonte 7
Chiswick 7
Kilburn 7
Palermo 7
Totale 8.937
Salva come PNG Salva come JPEG
Nome #
Haemodynamic validation of the three-step HFA-PEFF algorithm to diagnose heart failure with preserved ejection fraction 219
Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization 211
Clinical Value of a Novel Three-Dimensional Echocardiography–Derived Index of Right Ventricle–Pulmonary Artery Coupling in Tricuspid Regurgitation 181
Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure with Preserved Ejection Fraction 170
Impact of COVID-19 on exercise pathophysiology: A combined cardiopulmonary and echocardiographic exercise study 164
Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: A meta-analysis 164
Right Heart Adaptation to Exercise in Pulmonary Hypertension: An Invasive Hemodynamic Study 161
Cluster analysis of advanced invasive hemodynamics in heart failure with preserved ejection fraction 161
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 159
Upward shift and steepening of the blood pressure response to exercise in hypertensive subjects at high altitude 159
Cardiac magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities 157
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison 157
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 155
Hemodynamic phenotyping of pulmonary hypertension in left heart failure 151
Ambulatory Blood Pressure in Untreated and Treated Hypertensive Patients at High Altitude: The High Altitude Cardiovascular Research-Andes Study 151
Impact of correcting the 2D PISA method on the quantification of functional tricuspid regurgitation severity 150
An updated meta-analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease 150
Do the remodeling effects of sacubitril/valsartan treatment depend upon heart failure duration? 149
Systemic Sclerosis and Pulmonary Hypertension: The Great Masquerader 149
Pulmonary congestion at rest and abnormal ventilation during exercise in chronic systolic heart failure 149
Interatrial Shunt Devices 148
Incremental Value of Right Atrial Strain Analysis to Predict Atrial Fibrillation Recurrence after Electrical Cardioversion 146
Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component 145
Impact of COVID-19 lockdown on exercise capacity in PAH patients 144
Blood pressure at high altitude: Physiology and clinical implications 144
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 144
Management of anticoagulant therapy in the follow-up of pulmonary embolism in clinical practice 142
Understanding mechanisms of Fontan failure: exercise haemodynamics to unmask diastolic dysfunction, again! 142
Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation 142
Ipertensione polmonare pre-capillare o post-capillare? Il ruolo dei test provocativi in sala di emodinamica = Pulmonary hypertension: pre- or post-capillary? The role of provocative tests in the cath lab 142
Blood pressure response to six-minute walk test in hypertensive subjects exposed to high altitude: Effects antihypertensive combination treatment 141
Hyperparathyroidism in celiac disease: always secondary? 141
The Added Value of 3-Dimensional Echocardiography to Understand the Pathophysiology of Functional Tricuspid Regurgitation 140
The right side of the circulation in not secondary heart failure with preserved ejection fraction: an elephant in the room? 140
Proposta di una lettera di dimissione standardizzata dopo ospedalizzazione per embolia polmonare acuta 138
Shedding Light on Latent Pulmonary Vascular Disease in Heart Failure With Preserved Ejection Fraction 138
Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion 137
Acute high-altitude exposure reduces lung diffusion: Data from the HIGHCARE Alps project 137
Right ventricular reserve in cardiopulmonary disease: a simultaneous hemodynamic and three-dimensional echocardiographic study 136
Discrepancy in the Diagnosis of Heart Failure With Preserved Ejection Fraction Between Supine Versus Upright Exercise Hemodynamic Testing 136
Pulmonary arterial hypertension associated with a von Hippel-Lindau gene mutation 136
Decreased pulmonary vascular distensibility in adolescents conceived by in vitro fertilization 135
Atrial Functional Tricuspid Regurgitation as a Distinct Pathophysiological and Clinical Entity: No Idiopathic Tricuspid Regurgitation Anymore 135
Impact of severe secondary tricuspid regurgitation on rest and exercise hemodynamics of patients with heart failure and a preserved left ventricular ejection fraction 134
Association of outcome with left ventricular volumes and ejection fraction measured with two- and three-dimensional echocardiography in patients referred for routine, clinically indicated studies 133
Do Existing Definitions Identify Subgroup Phenotypes or Reflect the Natural History of Heart Failure with Preserved Ejection Fraction? 133
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 133
Reply to: ‘The hyperdynamic circulatory profile of patients with COVID-19-related acute vascular distress syndrome’ 132
Takayasu arteritis with aortic coarctation and multiple stenosis of aortic branches 132
Ischemic changes in exercise ECG in a hypertensive subject acutely exposed to high altitude. Possible role of a high-altitude induced imbalance in myocardial oxygen supply-demand 132
Current gaps in HFpEF trials: Time to reconsider patients' selection and to target phenotypes 131
CPET for Long COVID-19 130
Assessment of left ventricular diastolic function by three-dimensional transthoracic echocardiography 130
The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension 128
Noninvasive versus invasive pressure–flow relationship of the pulmonary circulation: Bias and error 128
Corrigendum: The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype 126
Pulmonary arterial hypertension 126
Long-term effects of intermittent Iloprost infusion on pulmonary arterial pressure in connective tissue disease 126
Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component 123
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 122
Heart failure and sleep related breathing disorders: Data from PROMISES (Progetto Multicentrico Italiano Sonno e Scompenso Cardiaco) study 122
Right heart chambers geometry and function in patients with the atrial and the ventricular phenotypes of functional tricuspid regurgitation 122
The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype 121
Pulmonary artery wedge pressure and left ventricular end-diastolic pressure during exercise in patients with dyspnoea 121
The Conundrum of HFpEF Definition: Non-Invasive Assessment Uncertainties and Alternative Diagnostic Strategies 120
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 119
Diagnostic and therapeutic models for the management of acute pulmonary embolism: An issue of local available resources 119
Phenotyping long COVID 119
Statement ANMCO: Tromboembolismo arterioso e venoso: quali implicazioni per la pratica clinica? 118
Obstructive Ventilatory Disorder in Heart Failure—Caused by the Heart or the Lung? 118
Recent advances in multimodality imaging of the tricuspid valve 118
Pulmonary arterial hypertension-associated genetic variants in combined post-capillary and pre-capillary pulmonary hypertension: a case report 117
Exercise stress echocardiography of the pulmonary circulation and right ventricular-arterial coupling in healthy adolescents 117
Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol 117
Stiff left atrial syndrome after low-dose radiotherapy for right breast cancer: The need for invasive hemodynamics at exercise 116
Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database 116
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 115
Blood pressure response in miners exposed to chronic intermittent hypoxia in Chile 114
Sildenafil therapy for interferon-β-1a-induced pulmonary arterial hypertension: A case report 113
ANMCO Position paper: Pulmonary circulation diseases and COVID-19 113
Pulmonary vascular function and exercise capacity in black sub-Saharan Africans 112
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function 111
Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test 111
Corrigendum to “Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database” [Int J Cardiol. 2020 Oct 15; 317: 103–110. PMID: 32360652] (International Journal of Cardiology (2020) 317 (103–110), (S0167527320312663), (10.1016/j.ijcard.2020.04.079)) 110
Heart failure with preserved ejection fraction and COVID-19: which comes first, the chicken or the egg? Letter regarding the article ‘Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings’ 109
Central sleep apnea during continuous positive airway pressure therapy in obstructive sleep apnea patients: From the compliance to adaptation, maladaptation and reflexes 108
Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude 108
Personalized exercise prescription as a tool for hypertension management and cardiovascular prevention: Evidence and pending issues 107
Corrigendum to 'Acute high-altitude exposure reduces lung diffusion: Data from the HIGHCARE Alps Project' [Respir. Physiol. Neurobiol. 188, (2013), 223-228] 106
Heart failure and anemia: Effects on prognostic variables 106
Role of acetazolamide and telmisartan/nifedipine-GITS combination in antagonizing the blood pressure rise induced by high altitude exposure 103
Why Do Exercise Hemodynamics Matter? 103
Exercise haemodynamics in heart failure with preserved ejection fraction: a systematic review and meta-analysis 102
Alterations of cardiovascular complexity during acute exposure to high altitude: A multiscale entropy approach 97
Blood Pressure Response to Exercise in Hypertensive Subjects Exposed to High Altitude and Treatment Effects 97
Pulmonary Hypertension Associated with Left Heart Disease 93
Invasive haemodynamic assessment in heart failure with preserved ejection fraction 93
Blood pressure and high altitude: physiological response and clinical management 90
Determinants of Right Heart Hemodynamic Derangement in Patients With and Without Tricuspid Regurgitation 89
Pick Your Threshold: A Comparison Among Different Methods of Anaerobic Threshold Evaluation in Heart Failure Prognostic Assessment 85
Totale 13.090
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.199
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.199
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/20221.433 79 300 213 14 120 179 90 58 83 96 154 47
2022/2023882 179 133 168 81 28 43 26 58 44 17 77 28
2023/20243.546 47 53 101 68 87 711 2.216 86 56 5 4 112
2024/20252.975 102 248 85 356 99 32 29 122 363 796 400 343
2025/20265.229 224 324 564 867 771 455 773 386 516 349 0 0
Totale 14.083